Comments Regarding Quantitative Labeling of Sodium, Potassium, and Phosphorus for OTC and Prescription Drug Products Share page: Docket Number: FDA-2021-D-0528 Download Document Issues: OTC Medicines Other Issues Labeling Quality Related Posts Press Releases and Statements CHPA Responds to HHS/FDA Announcement to Phase Out Petroleum-based Synthetic Dyes from America’s Food Supply Apr 22, 2025 Press Releases and Statements Health In Hand Foundation Announces Call for Nominations: 2025 U.S. Self-Care Marketing Awards Apr 22, 2025 Press Releases and Statements CHPA Applauds White House Executive Order Prioritizing Lower Drug Costs and Access to Self-Care Apr 17, 2025